IMMUNOLOGICAL AND HEMATOLOGICAL STATUS PROFILE IN TUBERCULOSIS-HUMAN IMMUNODEFICIENCY VIRUS COINFECTED PATIENTS

Isi Artikel Utama

Rizana Fajrunni'mah
Niniek Dwi Febriyana

Abstrak

Infeksi oleh Human Immunodeficiency Virus (HIV) merupakan masalah di seluruh dunia termasuk Indonesia. Tuberkulosis (TB) adalah infeksi oportunistik tersering pada penderita AIDS. Status imun pada penderita terinfeksi HIV dapat dinilai melalui pemeriksaan jumlah absolut limfosit T CD4+, dan ini merupakan standar untuk menilai dan menentukan derajat imunodefisiensi. Penurunan progresif limfosit T CD4+ berhubungan dengan progresifitas penyakit. Penelitian ini bertujuan mengetahui profil status imunologis yang dilihat dari jumlah CD4 dan hematologi yang dilihat dari jumlah leukosit, hitung jenisnya, hemoglobin, laju endap darah, dan trombosit. Penelitian ini menggunakan rancangan kuantitatif dengan desain analitik observasional (cross sectional).Jumlah data yang diambil sebanyak 45 data. Data dianalisis menggunakan analisis korelasi. Jumlah CD4+ pasien ko-infeksi TB-HIV terbanyak menunjukkan  imunodefisiensi berat (jumlah CD4+ <200 sel/ mm3) yaitu 73,3% pasien dengan rerata 118,4 sel/ mm3. Terdapat 86,5% mengalami anemia. Hitung jumlah dan jenis leukosit terbanyak yaitu jumlah leukosit normal sebanyak 59,5%, sebanyak 61,5% mengalami neutrofilia, sebanyak 65,4% mengalami limfopenia, monosit dalam rentang normal yaitu sebesar 57,7%. Sebanyak 73,7% mengalami peningkatan dengan rerata laju endap darah pasien mencapai 46,58 mm/jam. Jumlah trombosit terbanyak dalam rentang normal yaitu sebesar 68,6%. Terdapat korelasi yang signifikan antara kadar hemoglobin, hitung jumlah neutrofil, limfosit, dan monosit dengan hitung jumlah CD4+ dengan nilai p berturut-turut yaitu 0,001; 0,000; 0,000; 0,012. Status imunologis dan hematologi pasien koinfeksi TB-HIV mengalami penurunan, dan terdapat korelasi yang signifikan antara kedua profil tersebut, sehingga perlu meningkatkan pemeriksaan laboratorium secara menyeluruh.

Rincian Artikel

Cara Mengutip
Fajrunni’mah, R., & Febriyana, N. D. (2022). IMMUNOLOGICAL AND HEMATOLOGICAL STATUS PROFILE IN TUBERCULOSIS-HUMAN IMMUNODEFICIENCY VIRUS COINFECTED PATIENTS . Media Penelitian Dan Pengembangan Kesehatan, 32(4), 1-15. https://doi.org/10.34011/jmp2k.v32i4.1864


Bagian
Articles

Referensi

G. A. Roth et al., “Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017,” Lancet, vol. 392, no. 10159, pp. 1736–1788, 2018.

Kementerian Kesehatan RI, “Laporan Perkembangan HIV AIDS & Infeksi Menular Seksual (IMS),” 2017. [Online]. Available: https://siha.kemkes.go.id/portal/files_upload/Laporan_HIV_AIDS_TW_4_Tahun_2017__1_.pdf.

W. H. Organization, “Global tuberculosis report executive summary,” Geneva World Heal. Organ., 2018.

E. Puspitasari, E. Yunihastuti, I. Rengganis, and C. M. Rumende, “Prediktor mortalitas pasien HIV/AIDS rawat inap,” J. penyakit dalam Indones., vol. 3, no. 1, pp. 22–28, 2016.

Kementerian Kesehatan RI, “Petunjuk teknis tata laksana klinis ko-infeksi TB-HIV,” Jakarta KemenKes RI, p. 150, 2012.

M. Meidani, F. Rezaei, M. R. Maracy, M. Avijgan, and K. Tayeri, “Prevalence, severity, and related factors of anemia in HIV/AIDS patients,” J. Res. Med. Sci., vol. 17, no. 2, p. 138, 2012.

E. C. Russell, S. Charalambous, L. Pemba, G. J. Churchyard, A. D. Grant, and K. Fielding, “Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study,” BMC Public Health, vol. 10, no. 1, pp. 1–8, 2010.

C. C. Affusim, E. Kesieme, and V. O. Abah, “The pattern of presentation and prevalence of tuberculosis in HIV-seropositive patients seen at Benin City, Nigeria,” Int. Sch. Res. Not., vol. 2012, 2012.

S. Sen et al., “Correlation of CD4+ T cell count with total lymphocyte count, haemoglobin and erythrocyte sedimentation rate levels in human immunodeficiency virus type-1 disease,” Med. J. Armed Forces India, vol. 67, no. 1, pp. 15–20, 2011.

M. Wesnawa and I. Putra, “Profil Pasien Koinfeksi TB–HIV,” J. Respirologi Indones., vol. 36, pp. 175–181, 2016.

F. Kirchhoff and G. Silvestri, “Is Nef the elusive cause of HIV-associated hematopoietic dysfunction?,” J. Clin. Invest., vol. 118, no. 5, pp. 1622–1625, 2008.

F. Cottrez, F. Manca, A. G. Dalgleish, F. Arenzana-Seisdedos, A. Capron, and H. Groux, “Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.,” J. Clin. Invest., vol. 99, no. 2, pp. 257–266, 1997.

World Health Organization (WHO), WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization, 2007.

Z. Djoerban, E. Yunihastuti, A. Uyainah, and Z. Amin, “Profil Pasien Tb-hiv dan Non Tb-hiv di Rscm,” Indones. Bull. Heal. Res., vol. 41, no. 4, p. 20061, 2013.

D. Soraya and D. M. Artika, “Profil Pasien Koinfeksi TB-HIV Di Rumah Sakit Umum Pusat Sanglah Bali Tahun 2013,” EJURNAL Med, vol. 5, no. 20, pp. 66–71, 2016.

M. Widiyanti, E. Fitriana, and E. Iriani, “Karakteristik pasien koinfeksi tb-hiv di rumah sakit mitra masyarakat mimika papua,” 2019.

Kementerian Kesehatan RI, “Laporan Situasi Perkembangan HIV-AIDS & PIMS di Indonesia,” Jakarta, pp. 2–21, 2017.

D. A. Permitasari and M. A. U. Sofro, “Faktor Risiko Terjadinya Koinfeksi Tuberkulosis pada Pasien HIV/AIDS di Rsup Dr. Kariadi Semarang.” Fakultas Kedokteran, 2012.

W. Jayakody, A. D. Harries, S. Malhotra, S. De Alwis, S. Samaraweera, and N. Pallewatta, “Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka,” Public Heal. Action, vol. 3, no. 1, pp. 26–30, 2013.

C. Nzou, R. A. Kambarami, F. E. Onyango, C. E. Ndhlovu, and V. Chikwasha, “Clinical predictors of low CD4 count among HIV-infected pulmonary tuberculosis clients: A health facility-based survey,” South African Med. J., vol. 100, no. 9, pp. 602–605, 2010.

A. J. Sunggoro, Z. Amin, and C. M. Rumende, “Mortality among Hospitalized HIV-Infected Patients with Tuberculosis in Cipto Mangunkusumo Hospital, Jakarta, Indonesia: A Retrospective Cohort Study,” 2014.

A. V. Rajkondawar and V. Rodge, “Correlation Between Clinical Profile, Total Lymphocytic Count And CD4 Count In HIV Positive Patients,” Blood Transfus., vol. 4, p. 4, 2017.

S. K. Sharma, A. Mohan, and T. Kadhiravan, “HIV-TB co-infection: epidemiology, diagnosis & management,” Indian J. Med. Res., vol. 121, no. 4, pp. 550–567, 2005.

J. Elston and H. Thaker, “Co-infection with human immunodeficiency virus and tuberculosis,” Indian J. Dermatol. Venereol. Leprol., vol. 74, no. 3, p. 194, 2008.

G. C. De Santis et al., “Hematological abnormalities in HIV-infected patients,” Int. J. Infect. Dis., vol. 15, no. 12, pp. e808–e811, 2011.

S. Jam et al., “A cross-sectional study of anemia in human immunodeficiency virus-infected patients in Iran,” Arch Iran Med, vol. 12, no. 2, pp. 145–150, 2009.

M. Taha, A. Deribew, F. Tessema, S. Assegid, L. Duchateau, and R. Colebunders, “Risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a case control study,” Ethiop. J. Health Sci., vol. 21, no. 2, pp. 131–140, 2011.

T. Kufa et al., “Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control,” JAIDS J. Acquir. Immune Defic. Syndr., vol. 60, no. 2, pp. e22–e28, 2012.

A. S. Atmadja, R. Kusuma, and F. Dinata, “Pemeriksaan laboratorium untuk membedakan infeksi bakteri dan infeksi virus,” CDK-241, vol. 43, no. 6, pp. 457–461, 2016.

A. A. Maharani, “Profil Leukosit Pasien Tuberkulosis (TB) Paru di Rumah Sakit Paru Respira Yogyakarta,” Universitas Islam Indonesia, 2018.

V. Goyal, P. N. Vaish, A. Deshmukh, J. Mishra, and G. Deshmukh, “Hematological Study (Blood & Bone Marrow) in HIV Patients,” Int. J. Contemp. Med., vol. 4, no. 1, pp. 94–99, 2016.

R. Wirawan, Pemeriksaan Laboratorium Hematologi. Jakarta: Badan Penerbit FKUI, 2011.

N. Suastika, “Akurasi Diagnostik Kombinasi Total Lymphocyte Count (TLC) Dan Kadar Hemoglobin Untuk Memprediksi Imunodefisiensi Berat Pada Penderita Terinfeksi Human Immunodeficiency Virus (HIV) Pra Terapi Antiretroviral,” Universitas Udayana Denpasar, 2013.

P. Agustina, H. Rahmawati, A. Rusli, T. Sundari, and I. B. S. Wiweka, “Profil Pasien Suspek Resistensi Ganda Tuberkulosis HIV/AIDS di Rumah Sakit Penyakit Infeksi (RSPI) Prof. Dr. Sulianti Saroso Tahun 2012.,” Indones. J. Infect. Dis., vol. 3, no. 1, pp. 1–7, 2017.

R. Kumar, “Comparison between CD4 count, haematological manifestations and respiratory tract infections in HIV seropositive individuals,” Int. J. Contemp. Med. Res., vol. 3, no. 5, pp. 1245–1248, 2016.

G. Guadagnino et al., “Monocyte to lymphocyte blood ratio in tuberculosis and HIV patients: Comparative analysis, preliminary data.” Pharmacologyonline, 2017.

S. Longanbach, M. K. Miers, E. M. Keohane, L. J. Smith, and J. M. Walenga, Rodak’s hematology: Clinical principles and applications. St. Louis: Elsevier Saunders, 2016.

A. Oehadin, Aspek Hematologi Tuberkulosis. Bandung: Fakultas Kedokteran Universitas Padjajaran, 2003.

K. Bochen, A. Krasowska, S. Milaniuk, M. Kulczynska, A. Prystupa, and G. Dzida, “Erythrocyte sedimentation rate–an old marker with new applications,” J. Pre-clinical Clin. Res., vol. 5, no. 2, 2011.

W. L. Ningrum, “Profil laju endap darah pada pasien tuberkulosis paru kasus baru di RSU Kota Tangerang Selatan.” UIN Syarif Hidayatullah Jakarta: Fakultas Kedokteran dan Ilmu Kesehatan, 2017, 2017.

K. Rohini, M. S. Bhat, P. S. Srikumar, and A. M. Kumar, “Assessment of hematological parameters in pulmonary tuberculosis patients,” Indian J. Clin. Biochem., vol. 31, no. 3, pp. 332–335, 2016.

W. Y. Niu, Y. G. Wan, M. Y. Li, Z. X. Wu, L. G. Zhang, and J. X. Wang, “The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis,” Eur Rev Med Pharmacol Sci, vol. 17, no. 24, pp. 3329–3333, 2013.

M. I. D. Pramudianti and T. Tahono, “Korelasi Antara Hitung Trombosit Dengan Jumlah CD4 Pasien HIV/AIDS,” Indones. J. Clin. Pathol. Med. Lab., vol. 17, no. 2, pp. 102–106, 2018.

N. B. Sianipar, “Trombositopenia dan berbagai penyebabnya,” Cermin Dunia Kedokt., vol. 41, no. 6, pp. 416–421, 2014.

K. R. McCrae, Thrombocytopenia. New York: CRC Press, 2006.

E.-J. Lee and A. I. Lee, “Thrombocytopenia,” Prim. Care Clin. Off. Pract., vol. 43, no. 4, pp. 543–557, 2016.

N. M. Lasut, L. W. A. Rotty, and E. B. I. Polii, “Gambaran Kadar Hemoglobin Dan Trombosit Pada Pasien Tuberkulosis Paru di RSUP. Prof. Dr. Rd Kandou Manado Periode Januari 2014–Desember 2014,” e-CliniC, vol. 4, no. 1, 2016.

C. Obirikorang and F. A. Yeboah, “Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting,” J. Biomed. Sci., vol. 16, no. 1, pp. 1–7, 2009.

T. Sokoya, H. C. Steel, M. Nieuwoudt, and T. M. Rossouw, “HIV as a cause of immune activation and immunosenescence,” Mediators Inflamm., vol. 2017, 2017.

B. Gunawan, “Stres dan sistem imun tubuh: suatu pendekatan psikoneuroimunologi,” Cermin Dunia Kedokt., vol. 154, pp. 13–15, 2007.